Zoetis (ZTS) Receivables - Other (2012 - 2025)
Zoetis' (ZTS) quarterly Receivables - Other came in at $69.0 million in Q4 2025, down 12.66% year-on-year from $79.0 million in Q4 2024, and down 12.66% on a QoQ basis from $79.0 million in Q4 2024.
Zoetis (ZTS) Receivables - Other (2012 - 2025) Analysis & Trends
Zoetis (ZTS) has 14 years of Receivables - Other data on file, last reported at $69.0 million in Q4 2025.
- On a quarterly basis, Receivables - Other fell 12.66% year-over-year to $69.0 million in Q4 2025; TTM through Dec 2025 was $69.0 million, a 12.66% decrease from a year earlier, with the FY2025 full-year figure at $69.0 million, down 12.66% from the prior year.
- Receivables - Other for Q4 2025 stood at $69.0 million, down from $79.0 million in the prior quarter.
- Over the last five years, Receivables - Other for ZTS reached as high as $79.0 million in Q4 2024 and fell as low as $47.0 million in Q4 2021.
- Historically, Receivables - Other has averaged $64.8 million across 5 years, with a median of $69.0 million in 2025.
- Across the five-year window, Receivables - Other jumped 51.06% in 2022 and dropped 18.31% in 2023, its largest moves.
- Year by year, Receivables - Other stood at $47.0 million in 2021, then surged by 51.06% to $71.0 million in 2022, then slipped by 18.31% to $58.0 million in 2023, then jumped by 36.21% to $79.0 million in 2024, then dropped by 12.66% to $69.0 million in 2025.
- Per Business Quant data, the three most recent Receivables - Other figures were $69.0 million in Q4 2025, $79.0 million in Q4 2024, and $58.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.00 Mn |
| Dec 31, 2025 | 69.00 Mn |
| Dec 31, 2024 | 79.00 Mn |
| Dec 31, 2024 | 79.00 Mn |
| Dec 31, 2023 | 58.00 Mn |
| Dec 31, 2023 | 58.00 Mn |
| Dec 31, 2022 | 71.00 Mn |
| Dec 31, 2022 | 71.00 Mn |
| Dec 31, 2021 | 47.00 Mn |
| Dec 31, 2021 | 47.00 Mn |
| Dec 31, 2020 | 48.00 Mn |
| Dec 31, 2020 | 48.00 Mn |
| Dec 31, 2019 | 37.00 Mn |
| Dec 31, 2019 | 37.00 Mn |
| Dec 31, 2018 | 41.00 Mn |
| Dec 31, 2018 | 41.00 Mn |
| Dec 31, 2017 | 62.00 Mn |
| Dec 31, 2017 | 62.00 Mn |
| Dec 31, 2016 | 49.00 Mn |
| Dec 31, 2016 | 49.00 Mn |